|

Multimodal Glucose Prediction in Type 2 Diabetes

RECRUITINGSponsored by Johns Hopkins University
Actively Recruiting
SponsorJohns Hopkins University
Started2026-10-07
Est. completion2027-01-15
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
Locations1 site

Summary

The primary objective of this research, funded by Samsung Strategic Alliance for Research and Technology, is to develop multi-modal foundation models that integrate Continuous Glucose Monitoring (CGM) data with patient behavior data (food intake, medication, and physical activity) to improve real-time glucose prediction and personalized diabetes management for patients with Type 2 diabetes (T2D), delivered via mobile apps and digital health tools.

Eligibility

Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* 18-75 years old
* Registered patient under Johns Hopkins Medicine (JHM)
* Type 2 Diabetes diagnosis
* Diabetes managed by a primary care physician or endocrinologist at JHM
* Android Smartphone user
* Must have a Dexcom G7 or FreeStyle Libre 3 CGM and using a mobile app to access their CGM data (G7 or Libre 3 apps)
* 2 weeks of usage (with at least 50% wear time) prior to study participation required
* CGM Time in Range of \<70% in 14 days prior to enrollment
* Must be able to read, understand, and communicate in English
* Must not have hearing or vision impairments
* Willingness to Download the Welldoc app
* Agree to wear a SAMSUNG Galaxy Watch at least 12 hours per day
* Download SAMSUNG Health (Non-SAMSUNG Phone user)
* Download Google Health Connect
* Use CGM at least 80% of the time
* Take a photo of all meals

Exclusion Criteria:

* Pregnant
* Non-English speaker
* Has hearing or vision impairment
* Use of an insulin pump (i.e. automated insulin delivery system)
* Diagnosed with other forms of diabetes (e.g. Type 1 Diabetes, Latent Autoimmune Diabetes in Adults (LADA), Maturity-Onset Diabetes of the Young (MODY), or Gestational diabetes)
* Non-Android smartphone user (i.e., Apple iOS)
* CGM time-below-range \> 4% (i.e. hypoglycemia) in the 14 days prior to enrollment.
* Hospitalization for Diabetic Ketoacidosis (DKA) or severe hypoglycemic episode within the previous 6 months.

Conditions2

DiabetesType 2 Diabetes

Locations1 site

Johns Hopkins Medicine
Nestoras Mathioudakis, MD, MHS410-955-3663nmathio1@jhmi.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.